Tandem Diabetes Care Overview
Tandem Diabetes Care Target Price
Analysts' 12-month price predictions for TNDM.
Get informed when a big investor buys or sells
+ FollowShare Price
$15.32
Average Target Price
$31.25
104% upside
104% upside6 analysts in the last 4 months
High: $55 | Low: $15.5
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-23 | Deutsche Bank | $15.5 | 1.2% upside |  |
| 2026-06-01 | Wells Fargo | $27 | 76.2% upside | |
| 2026-05-27 | Goldman Sachs | $21 | 37.1% upside | |
| 2026-05-11 | Barclays | $55 | 259% upside | |
| 2026-05-08 | Mizuho SecuritiesAnthony Petrone | $24 | 56.7% upside | |
| 2026-04-24 | Redburn PartnersIssie Kirby | $45 | 193.7% upside | |
| 2026-02-23 | Truist Financial | $27 | 76.2% upside | |
| 2026-02-23 | Lake Street | $50 | 226.4% upside | |
| 2026-02-23 | Goldman SachsDavid Roman | $28 | 82.8% upside | |
| 2026-02-23 | BarclaysMatt Miksic | $56 | 265.5% upside | |
| 2026-02-20 | Mizuho Securities | $22 | 43.6% upside | |
| 2026-02-20 | Stifel Nicolaus | $22 | 43.6% upside | |
| 2026-02-20 | UBS | $22 | 43.6% upside | |
| 2026-02-20 | Piper SandlerMatt O'Brien | $21 | 37.1% upside | |
| 2026-02-04 | Stifel Nicolaus | $20 | 30.5% upside | |
| 2026-01-09 | Goldman SachsDavid Roman | $25 | 63.2% upside | |
| 2025-12-18 | Truist Financial | $24 | 56.7% upside | |
| 2025-12-17 | RBC Capital | $30 | 95.8% upside | |
| 2025-12-17 | Canaccord GenuityWilliam Plovanic | $35 | 128.5% upside | |
| 2025-12-17 | Mizuho SecuritiesAnthony Petrone | $21 | 37.1% upside | |
| 2025-12-16 | Robert W. Baird | $30 | 95.8% upside | |
| 2025-12-02 | Morgan Stanley | $23 | 50.1% upside | |
| 2025-10-15 | Truist FinancialRichard Newitter | $16 | 4.4% upside | |
| 2025-09-08 | OppenheimerSuraj Kalia | $22 | 43.6% upside | |
| 2025-08-07 | Canaccord GenuityWilliam Plovanic | $24 | 56.7% upside | |
| 2025-08-07 | Piper SandlerMatt O'Brien | $14 |  8.6% downside | |
| 2025-03-05 | Morgan Stanley | $22 | 43.6% upside | |
| 2025-02-28 | Bernstein | $25 | 63.2% upside | |
| 2025-02-28 | Barclays | $53 | 246% upside | |
| 2025-01-08 | BernsteinLee Hambright | $44 | 187.2% upside | |
| 2024-11-07 | Robert W. BairdJeff Johnson | $37 | 141.5% upside | |
| 2024-11-05 | BernsteinLee Hambright | $42 | 174.2% upside | |
| 2024-10-04 | Goldman SachsDavid Roman | $46 | 200.3% upside | |
| 2024-10-02 | RBC CapitalShagun Singh | $65 | 324.3% upside | |
| 2024-08-08 | Canaccord GenuityWilliam Plovanic | $57 | 272.1% upside | |
| 2024-08-05 | BarclaysMatt Miksic | $58 | 278.6% upside | |
| 2024-08-02 | Piper SandlerMatt O'Brien | $55 | 259% upside | |
| 2024-08-02 | Robert W. BairdJeff Johnson | $39 | 154.6% upside | |
| 2024-06-10 | OppenheimerSteven Lichtman | $58 | 278.6% upside | |
| 2024-05-29 | Stifel NicolausMatthew Blackman | $60 | 291.6% upside | |
| 2024-05-22 | Lake StreetBrooks O'Neil | $75 | 389.6% upside | |
| 2024-05-03 | Piper SandlerMatt O'Brien | $50 | 226.4% upside | |
| 2024-05-03 | Robert W. BairdJeff Johnson | $36 | 135% upside | |
| 2024-04-29 | Wells FargoLawrence Biegelsen | $45 | 193.7% upside | |
| 2024-04-25 | Leerink PartnersDanielle AntalffyMike Kratky | $45 | 193.7% upside | |
| 2024-04-22 | Stifel NicolausMatthew Blackman | $40 | 161.1% upside | |
| 2024-04-11 | CFRAKenneth Leon | $36 | 135% upside | |
| 2024-03-25 | Stifel NicolausMathew Blackman | $37 | 141.5% upside | |
| 2022-08-17 | Raymond JamesJayson Bedford | $92 | 500.5% upside | |
| 2022-08-09 | Wells FargoLarry Biegelsen | $49 | 219.8% upside | |